{
    "Trade/Device Name(s)": [
        "BD Phoenix\u2122M Automated Microbiology System",
        "BD Phoenix\u2122M Automated Microbiology System for use with the antimicrobial agent Cefuroxime - 1-64 \u00b5g/mL - Gram-negative ID/AST or AST only Phoenix panels"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K062207",
    "Predicate Device Reference 510(k) Number(s)": [
        "N50510",
        "K020321",
        "K033362"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "September 13, 2006",
    "Summary Letter Received Date": "August 1, 2006",
    "Submission Date": "July 31, 2006",
    "Regulation Number(s)": [
        "21CFR866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility System"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Cefuroxime"
    ],
    "Specimen Type(s)": [
        "Pure culture isolates of Gram-negative aerobic and facultative anaerobic bacteria",
        "Gram-positive bacteria isolates (Staphylococcus, Enterococcus, Streptococcus)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix\u2122M Automated Microbiology System"
    ],
    "Method(s)/Technology(ies)": [
        "Broth microdilution",
        "Automated antimicrobial susceptibility testing",
        "Redox indicator detection"
    ],
    "Methodologies": [
        "Minimal inhibitory concentration (MIC) determination"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "System",
        "Panel",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix\u2122M Automated Microbiology System with Cefuroxime for automated antimicrobial susceptibility testing of bacterial isolates",
    "Indications for Use Summary": "Intended for in vitro quantitative determination of antimicrobial susceptibility by MIC of most Gram-negative and Gram-positive bacterial isolates from pure culture, including Enterobacteriaceae, Non-Enterobacteriaceae, Staphylococcus, Enterococcus, and Streptococcus, with expanded organism groups and removal of Klebsiella pneumoniae limitation",
    "fda_folder": "Microbiology"
}